These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Role of endorectal magnetic resonance spectroscopic imaging in two different Gleason scores in prostate cancer. Nagarajan R, Margolis D, McClure T, Raman S, Thomas MA. Med Princ Pract; 2011; 20(5):444-8. PubMed ID: 21757934 [Abstract] [Full Text] [Related]
24. A pilot study of endorectal magnetic resonance imaging and magnetic resonance spectroscopic imaging changes with dutasteride in patients with low risk prostate cancer. Chung HT, Noworolski SM, Kurhanewicz J, Weinberg V, Roach Iii M. BJU Int; 2011 Oct; 108(8 Pt 2):E164-70. PubMed ID: 21435153 [Abstract] [Full Text] [Related]
32. Image fusion of CT and MRI data enables improved target volume definition in 3D-brachytherapy treatment planning. Krempien RC, Daeuber S, Hensley FW, Wannenmacher M, Harms W. Brachytherapy; 2003 Sep; 2(3):164-71. PubMed ID: 15062139 [Abstract] [Full Text] [Related]
33. Automated vs. manual pattern recognition of 3D (1)H MRSI data of patients with prostate cancer. Zechmann CM, Menze BH, Kelm BM, Zamecnik P, Ikinger U, Giesel FL, Thieke C, Delorme S, Hamprecht FA, Bachert P. Acad Radiol; 2012 Jun; 19(6):675-84. PubMed ID: 22578226 [Abstract] [Full Text] [Related]
34. Use of MRI and spectroscopy in evaluation of external beam radiotherapy for prostate cancer. Pickett B, Kurhanewicz J, Coakley F, Shinohara K, Fein B, Roach M. Int J Radiat Oncol Biol Phys; 2004 Nov 15; 60(4):1047-55. PubMed ID: 15519774 [Abstract] [Full Text] [Related]
39. Diffusion tensor magnetic resonance imaging of prostate cancer. Manenti G, Carlani M, Mancino S, Colangelo V, Di Roma M, Squillaci E, Simonetti G. Invest Radiol; 2007 Jun 15; 42(6):412-9. PubMed ID: 17507813 [Abstract] [Full Text] [Related]